Previous 10 | Next 10 |
Outset Medical (OM) has started public stock offering that includes 2.5M shares in the primary offering and 2.5M in secondary. Price, actual size, and other terms not determined. The company has set underwriters' overallotment option to purchase up to an additional 0.75M shares.Joi...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today the commencement of a proposed underwritten public offering of 2,500,000 shares of its comm...
Outset Medical has seen continued commercial traction and provides a comforting guidance for 2021. While the guidance is strong, I still believe it might be conservative given the recent commercial traction and potential of the home market. Outset has everything going for itself t...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), the medical technology company that pioneered the Tablo Hemodialysis System, a first-of-its-kind device to reduce the cost and complexity of dialysis, is strengthening its consumer focus with the appointment of Andrea Saia ...
Chase Coleman’s 13F portfolio value increased from $35.5B to $39B this quarter. Tiger Global increased Uber Technologies, Snowflake, and DocuSign while decreasing Sunrun, Anaplan, MongoDB, and Twilio during the quarter. The largest three positions are JD.com, Microsoft, and...
The IPO market starts to pick back up with eight IPOs scheduled to raise $2.2 billion in the week ahead. Street research is expected for one company on Sunday, 3/14. Lock-up periods will be expiring for 15 companies. For further details see: U.S. IPO Week Ahead: The Spri...
The following slide deck was published by Outset Medical, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Outset Medical, Inc. 2020 Q4 - Results - Earnings Call Presentation
Outset Medical, Inc. (OM) Q4 2020 Earnings Conference Call March 9, 2021 17:00 ET Company Participants Lynn Lewis - Investor Relations Leslie Trigg - President & Chief Executive Officer Rebecca Chambers - Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Am...
Outset Medical (OM): Q4 Non-GAAP EPS of -$0.60 beats by $0.06; GAAP EPS of -$0.75 beats by $0.35.Revenue of $17.25M (+143.3% Y/Y) beats by $3.49M.Press Release For further details see: Outset Medical EPS beats by $0.06, beats on revenue
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2020. Recent H...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...